Oncosem Completes New Tender Process Worth TRY 133 Million
Oncosem has signed contracts totaling TRY 133,620,000 for chemotherapy drug preparation services with hospitals in Bursa and Ankara. In a statement to the Public Disclosure Platform (KAP), the company confirmed that the contracts have been signed and the process has been finalized. Under the new agreements, Oncosem will provide chemotherapy drug preparation services to the specified hospitals. These service procurement contracts are expected to directly and positively contribute to the company's revenue. Company officials stated that the signing of the contracts aims to increase operational capacity and expand market share in the healthcare sector. Oncosem has previously succeeded in similar public tenders, strengthening its presence in the industry. This is not investment advice.
📊 ONCSM — Piyasa Yorumu
▲ up · 60%Oncosem's completion of a new TRY 133 million tender process could positively contribute to the company's growth potential and cash flow. Technically, the RSI is at 45, in neutral territory, giving no overbought or oversold signals. The MACD line remains below the signal line, and the price trading below the SMA20 indicates short-term weakness. However, the positive news may trigger a recovery toward the SMA20. A short-term upward movement is possible, though volume and broader market trends should also be considered.
RSI 14
45.6
MACD
3.49
24h Δ
1.48%
Canlı Grafikler
🧬 Buna benzer
AI tarafından yeniden derlenmiştir. Yatırım tavsiyesi değildir.